SBFM Q4 2019 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$10,556-90.6% YoY

Gross Profit

$6,37160.4% margin

Operating Income

-$250,590-2373.9% margin

Net Income

-$396,618-3757.3% margin

EPS (Diluted)

$-2.11

QoQ Revenue Growth

+44.1%

Cash Flow

Operating Cash Flow

-$127,839

Free Cash Flow

-$128,699

Stock-Based Comp.

$125,200

Balance Sheet

Total Assets

$98,142

Total Liabilities

$833,527

Stockholders' Equity

-$735,385

Cash & Equivalents

$40,501

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10,556	$111,843	-90.6%
Gross Profit	$6,371	$14,477	-56.0%
Operating Income	-$250,590	-$149,135	-68.0%
Net Income	-$396,618	-$338,655	-17.1%